Concord Drugs Ltd — Others, 09-07-2025: AGM/EGM

Concord Drugs Limited has announced a board meeting on 31st July 2025 to consider increasing its authorized share capital from Rs. 11 Cr to Rs. 15.5 Cr to support fund-raising plans. The company proposes to raise up to Rs. 11.53 Cr through issuance of 31.75 lakh equity shares at Rs. 36.30 per share to promoters and identified non-promoter investors for working capital and to upgrade manufacturing facilities per revised cGMP 2022 guidelines. Additionally, it plans to raise Rs. 7.35 Cr via issuance of 20.25 lakh convertible warrants to promoters and select non-promoters, exercisable within 18 months, with proceeds primarily for regulatory compliance, modernization, and corporate purposes. The promoters will continue to hold controlling stakes post-issuance. All securities will be issued in dematerialized form and subject to lock-in as per applicable regulations.